News & Updates

Show Multimedia Only
Oral JAK inhibitor makes headway in alopecia areata

Oral JAK inhibitor makes headway in alopecia areata

05 Apr 2023 byElvira Manzano

Patients with severe alopecia areata (patchy baldness) had a dramatic hair regrowth, without serious adverse events, when treated with an investigational Janus kinase (JAK) inhibitor in the phase III THRIVE-AA2 study presented at AAD 2023.

05 Apr 2023